OSE IMMUNOTHERAPEUTICS |
Market Closed -
Other stock markets
|
After market 03:59:30 pm | |||
| 6.7 EUR | -0.74% |
|
6.7 | 0.00% |
| Apr. 17 | OSE: licensing agreement with AbbVie enters into force | CF |
| Apr. 17 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Other Biotechnology & Medical Research | -0.74% | +5.85% | +56.54% | +82.81% | +78.67% | 157M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- OSE Stock
- Charts OSE Immunotherapeutics
- Comparison Chart